The ESMO Preceptorship on NSCLC and SCLC 2025: Singapore is a two-day, in-person educational course focused on the management of Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC).

Scheduled for December 8–9, 2025, in Singapore, Republic of Singapore, the program is designed to provide attendees with a deep understanding of best clinical practices, including the use of immune checkpoint blockade and novel targeted agents for advanced NSCLC, as well as systemic treatment for SCLC and pleural mesothelioma. The preceptorship is co-chaired by Tony S.K. Mok and Solange Peters.”